Kolexia
Algrin Caroline Hématologie
Algrin Caroline
Hématologie
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, France
58 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie chronique lymphocytaire à cellules B Lymphomes Leucémie lymphoïde Leucémie prolymphocytaire Leucémie prolymphocytaire à cellules B Syndromes lymphoprolifératifs Lymphome B Maladie résiduelle

Collaborateurs

Voir plus
Leblond Véronique
Leblond Véronique
Hôpital Pitie Salpetriere, Paris, France
Lefebvre Christine
Lefebvre Christine
Hôpital Nord Grenoble, La Tronche, France
Maloum Karim
Maloum Karim
Hôpital Pitie Salpetriere, Paris, France
Leyronnas Cecile
Leyronnas Cecile
Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France

Industries

Voir plus
Janssen
11 collaboration(s)
Dernière en 2023
Pfizer
5 collaboration(s)
Dernière en 2023
Abbvie
4 collaboration(s)
Dernière en 2022
AstraZeneca
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Retrospective analysis of a cohort of 41 B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study).
Haematologica   01 juin 2023
What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort
Annual Meeting Abstracts 2022   15 novembre 2022
Characteristics and Outcomes of Adult Patients with T Prolymphocytic Leukemia: A Real World Study of the French Innovative Leukemia Group (FILO)
Annual Meeting Abstracts 2022   15 novembre 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Clinical and experimental rheumatology   16 mai 2022
Immunochemotherapy versus rituximab in anti-myelin-associated glycoprotein neuropathy: A report of 64 patients.
British journal of haematology   14 avril 2022
CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.
Cancers   24 novembre 2021
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.
The journal of pathology. Clinical research   09 août 2021
Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP-treated DLBCL.
HemaSphere   12 juin 2021
Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53.
Blood   28 février 2020
Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group
Blood   29 novembre 2018